4.0 Article Proceedings Paper

The amyloid precursor protein and its network of interacting proteins: physiological and pathological implications

Journal

BRAIN RESEARCH REVIEWS
Volume 48, Issue 2, Pages 257-264

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.brainresrev.2004.12.016

Keywords

Alzheimer's disease; signal transduction; ShcA; neurodegeneration

Categories

Funding

  1. Telethon [E.1144] Funding Source: Medline

Ask authors/readers for more resources

The amyloid precursor protein (APP) is an ubiquitous receptor-like molecule involved in the pathogenesis of Alzheimer's disease that generates beta-amyloid peptides and causes plaque formation. APP and some of its C-terminal proteolytic fragments (CTFs) have also been shown to be in the center of a complex protein-protein network, where selective phosphorylation of APP C-terminus may regulate the interaction with cytosolic phosphotyrosine binding (PTB) domain or Sre homology 2 (SH2) domain containing proteins involved in cell signaling. We have recently described an interaction between tyrosine-phosphorylated CTFs and ShcA adaptor protein which is highly enhanced in AD brain, and a new interaction between APP and the adaptor protein Grb2 both in human brain and in neuroblastoma cultured cells. These data suggest a possible role in cell signaling for APP and its CTFs, in a manner similar to that previously reported for other receptors, through a tightly regulated coupling with intracellular adaptors to control the signaling of the cell. In this review, we discuss the significance of these novel findings for AD development. (c) 2004 Published by Elsevier B.V.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.0
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available